Pills, PrEP, and Pals
Adherence, Stigma, Resilience, Faith and the Need to Connect Among Minority Women With HIV/Aids in a US HIV Epicenter
Bibliographic Data
| ID | 22066760 |
|---|---|
| Authors | Lunthita Duthely (0000-0002-9003-3257, University of Miami, corresponding author), Lunthita M Duthely, Alex P Sanchez-Covarrubias (0000-0002-0474-992X, University of Miami), Megan R Brown (0000-0003-3105-4688, University of Miami), Tanya Emmanuelle Thomas (0000-0001-6017-5636, University of Miami), Emily Montgomerie (0000-0001-8816-2300, University of Miami), Emily K Montgomerie, Sannisha K Dale (0000-0002-9516-239X, University of Miami), Sannisha Dale, Steven A Safren (0000-0002-0121-0806, University of Miami), Jonell E Potter, Jonell Potter (0000-0002-4620-2316, University of Miami) |
| Year | 2021 |
| Volume | 9 |
| Pages | 667331-667331 |
| Publication date | 2021-06-21 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2021.667331 |
| PMID | 34235129 |
| OpenAlex | W3173703524 |
| Language | EN |
| Citations received | 9 |
| References cited | 37 |
Background: Ending HIV/AIDS in the United States requires tailored interventions. This study is part of a larger investigation to design mCARES, a mobile technology-based, adherence intervention for ethnic minority women with HIV (MWH). Objective: To understand barriers and facilitators of care adherence (treatment and appointment) for ethnic MWH; examine the relationship between these factors across three ethnic groups; and, explore the role of mobile technologies in care adherence. Methods: Cross-sectional, mixed-methods data were collected from a cohort of African-American, Hispanic-American and Haitian-American participants. Qualitative data were collected through a focus group ( n = 8) to assess barriers and facilitators to care adherence. Quantitative data ( n = 48) surveyed women on depressive symptomology (PHQ-9), HIV-related stigma (HSS) and resiliency (CD-RISC25). We examined the relationships between these factors and adherence to treatment and care and across groups. Findings: Qualitative analyses revealed that barriers to treatment and appointment adherence were caregiver-related stressors (25%) and structural issues (25%); routinization (30%) and religion/spirituality (30%) promoted adherence to treatment and care. Caregiver role was both a hindrance (25%) and promoter (20%) of adherence to treatment and appointments. Quantitatively, HIV-related stigma differed by ethnic group; Haitian-Americans endorsed the highest levels while African-Americans endorsed the lowest. Depression correlated to stigma ( R = 0.534; p < 0.001) and resiliency ( R = −0.486; p < 0.001). Across ethnic groups, higher depressive symptomology and stigma were related to viral non-suppression ( p < 0.05)—a treatment adherence marker; higher resiliency was related to viral suppression. Among Hispanic-Americans, viral non-suppression was related to depression ( p < 0.05), and among African-Americans, viral suppression was related to increased resiliency ( p < 0.04). Conclusion: Multiple interrelated barriers to adherence were identified. These findings on ethnic group-specific differences underscore the importance of implementing culturally-competent interventions. While privacy and confidentiality were of concern, participants suggested additional intervention features and endorsed the use of mCARES as a strategy to improve adherence to treatment and appointments
Ethnic group · Family medicine · Focus group · Pill · Psychiatry · Psychological intervention · Adolescent Sexual and Reproductive Health · Clinical Psychology · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Nursing · Gerontology
Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S
What Women with HIV Know about Heart Health and Cardiovascular Risk and Intervention Preferences
Latent transition analysis of stigma and its association with treatment adherence in pulmonary tuberculosis patients during anti-tuberculosis therapy
Psychosocial Determinants of Antiretroviral Treatment Adherence among Black Mothers with HIV
Stigma in People Living with HIV/Aids in Brazil
Understanding how internalized HIV stigma affects messaging about adherence to antiretroviral treatment in women living with HIV in the southern United States
Racial disparities in the association between resilience and ART adherence among people living with HIV
Predictors of depression, anxiety, and overall psychological distress in people living with HIV/Aids
Why You Putting This Drug in Your Body to Fight off Something that You Don’t Have?” Perceptions About PrEP Use Among Black and Latino Men Who Have Sex with Men in the U.S. South
Stigma and racial/ethnic HIV disparities
A Systematic Review of Recent Smartphone, Internet and Web 2.0 Interventions to Address the HIV Continuum of Care
Ending the HIV Epidemic
Abuse and Resilience in Relation to Haart Medication Adherence and HIV Viral Load Among Women with HIV in the United States
Development of a new resilience scale
Measuring stigma in people with HIV
The PHQ-9
Ninety Minutes to Reduce One's Intention to Eat Meat
Digitized HIV/Aids Treatment Adherence Interventions
Co-designing eHealth and Equity Solutions
Resilience takes a village
Meta-analysis on the effect of text message reminders for HIV-related compliance
Validation of a New Three-Item Self-Report Measure for Medication Adherence
Enacted HIV-Related Stigma’s Association with Anxiety & Depression Among People Living with HIV (PLWH) in Florida
Mental Health, Coping, and Social Support Among People Living with HIV in the Americas
A Systematic Review and Meta-Analysis of Combination Behavioral Interventions Co-Targeting Psychosocial Syndemics and HIV-Related Health Behaviors for Sexual Minority Men
The Costs of Silencing the Self and Divided Self in the Context of Physical Abuse, Racial/Ethnic Identity, and Medication Adherence in Women Living with HIV
| Citations per year | 1.8 |
|---|---|
| Citation span | 2021 - 2026 (6) |
| Highly cited | No |